mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for UBR2
Gene summary
Basic gene Info.Gene symbolUBR2
Gene nameubiquitin protein ligase E3 component n-recognin 2
SynonymsC6orf133|bA49A4.1|dJ242G1.1|dJ392M17.3
CytomapUCSC genome browser: 6p21.1
Type of geneprotein-coding
RefGenesNM_001184801.1,
NM_015255.2,
DescriptionE3 ubiquitin-protein ligase UBR2ubiquitin-protein ligase E3-alpha-2ubiquitin-protein ligase E3-alpha-II
Modification date20141207
dbXrefs MIM : 609134
HGNC : HGNC
Ensembl : ENSG00000024048
HPRD : 09853
Vega : OTTHUMG00000014703
ProteinUniProt: Q8IWV8
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_UBR2
BioGPS: 23304
PathwayNCI Pathway Interaction Database: UBR2
KEGG: UBR2
REACTOME: UBR2
Pathway Commons: UBR2
ContextiHOP: UBR2
ligand binding site mutation search in PubMed: UBR2
UCL Cancer Institute: UBR2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0071233cellular response to leucine20298436


Top
Ligand binding site mutations for UBR2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H136R137QCOAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for UBR2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H136R137Q-1.1668663
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for UBR2 from PDB

Top
Differential gene expression and gene-gene network for UBR2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of UBR2 and the right PPI network was created from samples without mutations in the LBS of UBR2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for UBR2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for UBR2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of UBR2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)3ny2AH136
ZNZINC(2+)3ny2BH136
ZNZINC(2+)3ny2CH136
ZNZINC(2+)3ny2DH136
ZNZINC(2+)3ny2EH136
ZNZINC(2+)3ny2FH136
ZNZINC(2+)3ny2GH136
ZNZINC(2+)3ny2HH136
ZNZINC(2+)3ny3AH136


Top
Conservation information for LBS of UBR2
Multiple alignments for Q8IWV8 in multiple species
LBSAA sequence# speciesSpecies
A156CGDTEAWKEGP2Homo sapiens, Mus musculus
A156CGDADAWTEGY1Caenorhabditis elegans
A156CGDDEAWKKDQ1Drosophila melanogaster
C112EPTYSCRDCAV2Homo sapiens, Mus musculus
C112ELTYTCLDCAT1Caenorhabditis elegans
C112EPTYSCRECGV1Drosophila melanogaster
C115YSCRDCAVDPT2Homo sapiens, Mus musculus
C115YTCLDCATDGT1Caenorhabditis elegans
C115YSCRECGVDPT1Drosophila melanogaster
C121AVDPTCVLCME2Homo sapiens, Mus musculus
C121ATDGTCVMCLQ1Caenorhabditis elegans
C121GVDPTCVLCVN1Drosophila melanogaster
C124PTCVLCMECFL2Homo sapiens, Mus musculus
C124GTCVMCLQCFE1Caenorhabditis elegans
C124PTCVLCVNCFK1Drosophila melanogaster
C127VLCMECFLGSI2Homo sapiens, Mus musculus
C127VMCLQCFEVSI1Caenorhabditis elegans
C127VLCVNCFKRSA1Drosophila melanogaster
C149GGGGFCDCGDT2Homo sapiens, Mus musculus
C149SGSGYCDCGDA1Caenorhabditis elegans
C149GGGGCCDCGDD1Drosophila melanogaster
C151GGFCDCGDTEA2Homo sapiens, Mus musculus
C151SGYCDCGDADA1Caenorhabditis elegans
C151GGCCDCGDDEA1Drosophila melanogaster
C163KEGPYCQKHEL1Homo sapiens
C163TEGYACANHE-1Caenorhabditis elegans
C163KKDQYCELHLA1Drosophila melanogaster
C163KEGPYCQKHKL1Mus musculus
C99KPSHLCGRVFK2Homo sapiens, Mus musculus
C99R-GQICGHVFK1Caenorhabditis elegans
C99NTATVCGKVFK1Drosophila melanogaster
D150GGGFCDCGDTE2Homo sapiens, Mus musculus
D150GSGYCDCGDAD1Caenorhabditis elegans
D150GGGCCDCGDDE1Drosophila melanogaster
D153FCDCGDTEAWK2Homo sapiens, Mus musculus
D153YCDCGDADAWT1Caenorhabditis elegans
D153CCDCGDDEAWK1Drosophila melanogaster
F148SGGGGFCDCGD2Homo sapiens, Mus musculus
F148SSGSGYCDCGD1Caenorhabditis elegans
F148SGGGGCCDCGD1Drosophila melanogaster
G146TTSGGGGFCDC2Homo sapiens, Mus musculus
G146HSSSGSGYCDC1Caenorhabditis elegans
G146STSGGGGCCDC1Drosophila melanogaster
G147TSGGGGFCDCG2Homo sapiens, Mus musculus
G147SSSGSGYCDCG1Caenorhabditis elegans
G147TSGGGGCCDCG1Drosophila melanogaster
H133FLGSIHRDHRY2Homo sapiens, Mus musculus
H133FEVSIHKSHKY1Caenorhabditis elegans
H133FKRSAHRFHKY1Drosophila melanogaster
H136SIHRDHRYRMT2Homo sapiens, Mus musculus
H136SIHKSHKYKMH1Caenorhabditis elegans
H136SAHRFHKYKMS1Drosophila melanogaster
H166PYCQKHELNTS1Homo sapiens
H166YACANHE----1Caenorhabditis elegans
H166QYCELHLANRK1Drosophila melanogaster
H166PYCQKHKLSSS1Mus musculus
P119DCAVDPTCVLC2Homo sapiens, Mus musculus
P119DCATDGTCVMC1Caenorhabditis elegans
P119ECGVDPTCVLC1Drosophila melanogaster
T120CAVDPTCVLCM2Homo sapiens, Mus musculus
T120CATDGTCVMCL1Caenorhabditis elegans
T120CGVDPTCVLCV1Drosophila melanogaster
V122VDPTCVLCMEC2Homo sapiens, Mus musculus
V122TDGTCVMCLQC1Caenorhabditis elegans
V122VDPTCVLCVNC1Drosophila melanogaster


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas